GMAB Feb 2025 22.500 call
| Previous close | 6.00 |
| Open | 6.00 |
| Bid | 0.50 |
| Ask | 5.40 |
| Strike | 22.50 |
| Expiry date | 2025-02-21 |
| Day's range | 6.00 - 6.00 |
| Contract range | N/A |
| Volume | |
| Open interest | 6 |
GlobeNewswireMajor Shareholder Announcement
Company Announcement Major shareholder announcement for Genmab A/S COPENHAGEN, Denmark; October 4, 2024 – Genmab A/S (Nasdaq: GMAB) announces under reference to Section 30 of the Danish Capital Markets Act that Baillie Gifford & Co has informed us that, as of October 3, 2024, Baillie Gifford & Co held the voting rights to 3,301,530 shares in Genmab A/S, which amounts to 4.99% of the share capital and voting rights in Genmab A/S. About Genmab Genmab is an international biotechnology company with
Insider MonkeyIs Genmab A/S (GMAB) One of the Best Revenue Growth Stocks to Buy According to Analysts?
We recently published a list of the 7 Best Revenue Growth Stocks to Buy According to Analysts. In this article, we are going to take a look at where Genmab A/S (NASDAQ:GMAB) stands against the other best revenue growth stocks to buy according to analysts. The Fed recently cut the funds rate by 50 basis […]
- GlobeNewswire
Grant of Restricted Stock Units and Warrants to Employees in Genmab
Company Announcement COPENHAGEN, Denmark; September 26, 2024 – Genmab A/S (Nasdaq: GMAB) announced today that the Board decided to grant 23,954 restricted stock units and 13,915 warrants to employees of the Company and the Company's subsidiaries. Each restricted stock unit is awarded cost-free and provides the owner with a conditional right to receive one share in Genmab A/S of nominally DKK 1. The fair value of each restricted stock unit is equal to the closing market price on the date of grant
